On May 27, 2025, ZyVersa Therapeutics received a notice from Nasdaq about non-compliance due to its stock price being below $1.00 for 30 consecutive business days, risking delisting on June 5, 2025, unless they appeal by June 3, 2025.
AI Assistant
ZYVERSA THERAPEUTICS INC
2025
8 K
Find Answers
Ask about any part of the document to get insights, explanations, or key details.